These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 22964392)
1. Subcellular trafficking and transfection efficacy of polyethylenimine-polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1. Durymanov MO; Beletkaia EA; Ulasov AV; Khramtsov YV; Trusov GA; Rodichenko NS; Slastnikova TA; Vinogradova TV; Uspenskaya NY; Kopantsev EP; Rosenkranz AA; Sverdlov ED; Sobolev AS J Control Release; 2012 Oct; 163(2):211-9. PubMed ID: 22964392 [TBL] [Abstract][Full Text] [Related]
2. Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration. Durymanov MO; Yarutkin AV; Bagrov DV; Klinov DV; Kedrov AV; Chemeris NK; Rosenkranz AA; Sobolev AS J Control Release; 2016 Jun; 232():20-8. PubMed ID: 27072027 [TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. Ogris M; Walker G; Blessing T; Kircheis R; Wolschek M; Wagner E J Control Release; 2003 Aug; 91(1-2):173-81. PubMed ID: 12932649 [TBL] [Abstract][Full Text] [Related]
4. Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes. Kloeckner J; Prasmickaite L; Høgset A; Berg K; Wagner E J Drug Target; 2004 May; 12(4):205-13. PubMed ID: 15506169 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the transfection property of a peptide ligand for the fibroblast growth factor receptor as part of PEGylated polyethylenimine polyplex. Rao GA; Tsai R; Roura D; Hughes JA J Drug Target; 2008 Jan; 16(1):79-89. PubMed ID: 18172824 [TBL] [Abstract][Full Text] [Related]
14. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties. Zhong Z; Feijen J; Lok MC; Hennink WE; Christensen LV; Yockman JW; Kim YH; Kim SW Biomacromolecules; 2005; 6(6):3440-8. PubMed ID: 16283777 [TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. Chiu SJ; Ueno NT; Lee RJ J Control Release; 2004 Jun; 97(2):357-69. PubMed ID: 15196762 [TBL] [Abstract][Full Text] [Related]
16. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Rejman J; Bragonzi A; Conese M Mol Ther; 2005 Sep; 12(3):468-74. PubMed ID: 15963763 [TBL] [Abstract][Full Text] [Related]
17. Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Burke RS; Pun SH Bioconjug Chem; 2008 Mar; 19(3):693-704. PubMed ID: 18293906 [TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor gene loaded in cRGD-PEG-PEI suppresses colorectal cancer growth by targeting endothelial cells. Li L; Yang J; Wang WW; Yao YC; Fang SH; Dai ZY; Hong HH; Yang X; Shuai XT; Gao GQ Int J Pharm; 2012 Nov; 438(1-2):1-10. PubMed ID: 22974524 [TBL] [Abstract][Full Text] [Related]
19. Arginine-rich polyplexes for gene delivery to neuronal cells. Morris VB; Labhasetwar V Biomaterials; 2015 Aug; 60():151-60. PubMed ID: 26000961 [TBL] [Abstract][Full Text] [Related]
20. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. von Gersdorff K; Sanders NN; Vandenbroucke R; De Smedt SC; Wagner E; Ogris M Mol Ther; 2006 Nov; 14(5):745-53. PubMed ID: 16979385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]